Journals / Türk Kolon ve Rektum Hastalıkları Dergisi / 2017 / Cilt: 27 - Sayı: 3

The Prognostic Value of Lymph Node Ratio in Patients with Node-Positive Colorectal Cancer

Nod Pozitif Kolorektal Kanser Hastalarında Lenf Nodu Oranının Prognostik Önemi

Pages
76–83
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To determine the LNR threshold value that will separate patients in two prognostic groups with significantly different cancer-specific survival (CSS) rates, survival analyses were conducted with LNR threshold values between 0.05 and 0.95, at increments of 0.05.Results: In the whole series, the most significant LNR threshold value separating patients in low-risk (213 patients) and high-risk (108 patients) groups in terms of CSS was 0.40 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Lymph node metastasis is one of the most important prognostic factors in colorectal cancer.
📊
Key Findings & Data:We investigated the prognostic value of lymph node ratio (LNR); (the ratio of the number of metastatic lymph nodes to the number of removed lymph nodes) in node-positive colorectal cancer patients.Method: We assessed 321 node-positive colorectal cancer patients.
💡
Conclusion & Impact:To determine the LNR threshold value that will separate patients in two prognostic groups with significantly different cancer-specific survival (CSS) rates, survival analyses were conducted with LNR threshold values between 0.05 and 0.95, at increments of 0.05.Results: In the whole series, the most significant LNR threshold value separating patients in low-risk (213 patients) and high-risk (108 patients) groups in terms of CSS was 0.40 (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Lymph node metastasis is one of the most important prognostic factors in colorectal cancer. We investigated the prognostic value of lymph node ratio (LNR); (the ratio of the number of metastatic lymph nodes to the number of removed lymph nodes) in node-positive colorectal cancer patients.Method: We assessed 321 node-positive colorectal cancer patients. To determine the LNR threshold value that will separate patients in two prognostic groups with significantly different cancer-specific survival (CSS) rates, survival analyses were conducted with LNR threshold values between 0.05 and 0.95, at increments of 0.05.Results: In the whole series, the most significant LNR threshold value separating patients in low-risk (213 patients) and high-risk (108 patients) groups in terms of CSS was 0.40 (p

Özet

Amaç: Kolorektal kanserli hastalarda lenf nodu metastazı en önemli prognostik faktörlerden biridir. Biz nod-pozitif kolorektal kanserli hastalarda lenf nodu oranının (LNO); (metastatik lenf nodu sayısının çıkarılan lenf nodu sayısına oranı) prognostik değerini araştırdık. Yöntem: Biz 321 nod-pozitif kolorektal kanserli hastayı değerlendirdik. Hastaları anlamlı derecede farklı kansere özgü sağkalım (KÖS) oranlarına göre iki prognostik gruba ayıracak LNO eşik değerini belirlemek için, sağkalım analizleri LNO eşik değeri 0,05 arttırılarak 0,05 ve 0,95 arasında yapıldı.Bulgular: Tüm serilerde, hastaları KÖS açısından düşük risk (213 hasta) ve yüksek risk (108 hasta) gruplarına ayıran en anlamlı LNO eşik değeri 0,40 (p

🔖

Cite This Article

HOT, S., DURAKER, N., ÇAYNAK, Z. C. (2022). The Prognostic Value of Lymph Node Ratio in Patients with Node-Positive Colorectal Cancer. Türk Kolon ve Rektum Hastalıkları Dergisi, Cilt: 27 - Sayı: 3, 76–83. https://ajindex.com/articles/634689

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Handbook. 7th ed. New York; Springer-Verlag. 2010
  2. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003;21:2912-2919
  3. Kelder W, Inberg B, Schaapveld M, Karrenbeld A, Grond J, Wiggers T, Plukker JT. Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands. Dis Colon Rectum 2009;52:260-267
  4. Hashiguchi Y, Hase K, Ueno H, Mochizuki H, Kajiwara Y, Ichikura T, Yamamoto J. Prognostic significance of the number of lymph nodes examined in colon cancer surgery: clinical application beyond simple measurement. Ann Surg 2010;251:872-881
  5. Kotake K, Honjo S, Sugihara K, Hashiguchi Y, Kato T, Kodaira S, Muto S, Koyama Y. Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol 2012;42:29-35
  6. Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Liang WY, Chen WS, Lin JK, Chang SC. The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg 2013;37:1927-1933
  7. Mekenkamp LJ, van Krieken JH, Marijnen CA, van de Velde CJ, Nagtegaal ID; Pathology Review Committee and the Co-operative Clinical Investigators. Lymph node retrieval in rectal cancer is dependent on many factors- the role of the tumor, the patient, the surgeon, the radiotherapist, and pathologist. Am J Surg Pathol 2009;33:1547-1553
  8. Dillman RO, Aaron K, Heinemann FS, McClure SE. Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer 2009;115:1840-1848
  9. Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer 2010;116:2560- 2570
  10. Elferink MA, Siesling S, Visser O, Rutten HJ, van Krieken JH, Tollenaar RA, Lemmens VE. Large variation between hospitals and pathology laboratories in lymph node evaluation in colon cancer and its impact on survival, a nationwide population-based study in the Netherlands. Ann Oncol 2011;22:110-117
  11. Nash GM, Row D, Weiss A, Shia J, Guillem JG, P